TheJobsMapOcuTerra Therapeutics jobs and careers
Boston, MA, United States
About OcuTerra Therapeutics
OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity
Founded in 2011 by Takeru Furuya and Tobias Ritter.
- Founded
- 2011
- Employees
- 1 to 10
- Total funding
- $35M
- Headquarters
- Boston
Leadership
The top of OcuTerra Therapeutics's org chart, with how many people report into each leader.
Susannah Sinozich
Senior Clinical Program Director
Bill Steinkrauss
CFO
Board
Barbara Ryan
Board Member
William H. Koster
Vice Chair
Robin Steele
Board Member
David S. Boyer
Advisory Board Member
Robert Ruffolo
Board Member
Peter Kaiser
Advisory Board Member
Jobs at OcuTerra Therapeutics
No open positions right now. Explore more companies on TheJobsMap.